Efficacy and Safety of Insulin Degludec versus Insulin Glargine: A Systematic Review and Meta-Analysis of Fifteen Clinical Trials.
Wei LiuXiao-Jie YangJing HuangPublished in: International journal of endocrinology (2018)
Compared with IGlar, IDeg is associated with equivalent glycemic control and a statistically significantly lower rate of nocturnal hypoglycemia in patients with T1DM and T2DM. In T2DM patients, IDeg also provides better results in terms of overall hypoglycemia.
Keyphrases
- glycemic control
- type diabetes
- blood glucose
- clinical trial
- weight loss
- end stage renal disease
- insulin resistance
- ejection fraction
- newly diagnosed
- chronic kidney disease
- blood pressure
- peritoneal dialysis
- obstructive sleep apnea
- prognostic factors
- adipose tissue
- randomized controlled trial
- physical activity
- metabolic syndrome
- sleep quality
- phase iii